I am a multi-award-winning journalist who pioneered investigative travel journalism and became USA TODAY's only investigative travel editor. I was a founding journalist of Conde Nast Traveler ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Eli Lilly and Company (NYSE: LLY) will participate in TD Cowen's 45th Annual Health Care Conference on March 4, 2025. Jake Van Naarden, executive vice president and president, Lilly Oncology ...

Stoller: We are. Brady: Between us, we talk to the coolest people ... One of the other themes that came up in that conversation and also with Eli Lilly CEO Dave Ricks, was really about the longevity ...

Whether it’s their effortlessly chic ensembles or dreamy table settings, these tastemakers know how to make the holidays look good ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...